C. R. Bard controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2020
Product-liability claims involving legacy Bard devices
BD continued to disclose substantial litigation and claims inherited or associated with Bard businesses, including cases involving surgical mesh and other medical devices. The matters included claims, settlements, and proceedings whose outcomes varied by product and jurisdiction.
2019
Transvaginal surgical-mesh litigation and FDA action
Bard's transvaginal surgical-mesh products were the subject of extensive product-liability litigation. Plaintiffs alleged complications including pain, erosion, and organ injury. In 2019, the FDA ordered manufacturers to stop selling and distributing mesh products specifically intended for transvaginal repair of pelvic organ prolapse.